Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 6/20 | 0.33 |
| ▸ | ACACB | O00763 | 2/20 | 0.32 |
| ▸ | TNIK | Q9UKE5 | 6/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.31 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3737550 | 0.92 | ALDH1A1 (0.39) | ALDH1A1EGLN1ACACBTNIKF2 | |
| SCHEMBL3740811 | 0.92 | ALDH1A1 (0.42) | ALDH1A1EGLN1ACACBTNIKF2 | |
| SCHEMBL3739362 | 0.92 | ALDH1A1 (0.34) | ALDH1A1EGLN1ACACBTNIKF2 | |
| SCHEMBL3799210 | 0.91 | EGLN1 (0.35) | ALDH1A1EGLN1ACACBF2GLA | |
| SCHEMBL13040721 | 0.91 | ALDH1A1 (0.44) | ALDH1A1EGLN1ACACBTNIKF2 | |
| SCHEMBL157007 | 0.89 | ALDH1A1 (0.33) | ALDH1A1ACACBF2GLAHPGD | |
| SCHEMBL3739395 | 0.88 | ALDH1A1 (0.32) | ALDH1A1EGLN1ACACBTNIKF2 | |
| SCHEMBL3728642 | 0.88 | EGLN1 (0.36) | ALDH1A1EGLN1ACACBF2GLA | |
| SCHEMBL3734199 | 0.86 | MEN1 (0.34) | ALDH1A1EGLN1ACACBTNIKF2 | |
| SCHEMBL13077951 | 0.85 | ALDH1A1 (0.39) | ALDH1A1EGLN1ACACBF2GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415272-B2 | Quinoline derivatives and their use as fungicides | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-09 | — | — | US | disclosed |
| US-8415272-B2 | Quinoline derivatives and their use as fungicides | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-09 | — | — | US | disclosed |
| US-8415272-B2 | Quinoline derivatives and their use as fungicides | SYNGENTA CROP PROTECTION LLC (US) | 2013-04-09 | — | — | US | disclosed |
| US-20100280068-A1 | QUINOLINE DERIVATIVES AND THEIR USE AS FUNGICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-11-04 | — | — | US | disclosed |
| US-20100280068-A1 | QUINOLINE DERIVATIVES AND THEIR USE AS FUNGICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280068-A1 | QUINOLINE DERIVATIVES AND THEIR USE AS FUNGICIDES | CYP1A1, CYP3A7, CYP1A2 | ALDH1A1 350/4885EGLN1 985/4885ACACB 3700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.